Showing results (501-510 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|January 5, 2002
Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patientsSophie Marchal-Victorion, Nathalie Vionnet, Chantal Escrieut, et al.
Pharmacogenetics|January 5, 2002
Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin CRonald A Fleming, Jeffrey Drees, Brian W Loggie, et al.
Pharmacogenetics|January 5, 2002
Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeineLucia F Jorge-Nebert, Michel Eichelbaum, Ernst-U Griese, et al.
Pharmacogenetics|January 5, 2002
Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposisChristof Lamberti, Matthias Jungck, Michael Laarmann, et al.
Pharmacogenetics|July 27, 2002
Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variantJean-Marc Lo-Guidice, Delphine Allorge, Christelle Cauffiez, et al.
Pharmacogenetics|July 27, 2002
Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in SwedenEleni Aklillu, Karin Herrlin, Lars L Gustafsson, et al.
Pharmacogenetics|July 27, 2002
Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiolJose E Tanus-Santos, Mehul Desai, Leslie R Deak, et al.
Pharmacogenetics|July 27, 2002
Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's diseaseAnne-Sophie Rigaud, Latchezar Traykov, Florence Latour, et al.
Pharmacogenetics|February 4, 2003
Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer developmentJi-Yeob Choi, Josef Abel, Thomas Neuhaus, et al.
Pharmacogenetics|February 4, 2003
Monoamine oxidase polymorphisms and smoking behaviour in JapaneseHidemi Ito, Nobuyuki Hamajima, Keitaro Matsuo, et al.
Pageof 83